Skip to Content
Market Update

Earnings on Tap: Merck & Co

Shares of the drugmaker are trading in 4-star territory ahead of its earnings announcement Friday.


Drugmaker  Merck (MRK) is slated to post third-quarter earnings before the stock market opens Friday. Wall Street Analysts, on average, expect the firm to report earnings per share of $0.91, rising from $0.85 in the year-ago quarter.

The firm may focus on its expectations for Juvisync, approved by the FDA Oct. 7, a combination pill that helps patients with diabetes and high cholesterol. Personnel changes may also be in focus as the firm's chairman retires and some new senior-level executives are brought in.

Nazim Khan does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.